“The global slide stainers market projected to grow at a CAGR of 11.0%.”
The slide stainers market is expected to reach USD 4.70 billion by 2023 from an estimated USD 2.79 billion in 2018, at a CAGR of 11.0%. Increasing incidence of chronic diseases, rising geriatric population, growing automation in laboratories, and increasing healthcare expenditure are some of the factors driving the growth of the slide stainers market. However, the implementation of excise duty by the US government is expected to limit the growth of this market during the forecast period.
Request a Free Sample copy of This Premium Research Report: https://watchersofmarkets.com/products/slide-stainer-market-by-product-reagent-equipment-automated-manual-technology-hematoxylin-eosin-immunohistochemistry-in-situ-hybridization-microbiology-special-stains-end-user-hospital-pharmaceutical-academic-global-forecast-to-2023#tab-questions
“The reagents segment is expected to register the highest CAGR during the forecast period.”
On the basis of product, the slide stainer market is segmented into reagents, equipment, and consumables & accessories. The equipment segment is further subsegmented into automated slide stainers and manual slide staining sets. The reagents segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.
“Special staining to witness the highest growth during the forecast period.”
On the basis of technology, the slide stainers market is segmented into hematoxylin and eosin, immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special staining. The special staining is expected to witness the highest CAGR owing to the fact that this technique provides additional information which cannot be obtained with H&E routine staining technique. In addition, it also enables researchers to differentiate between normal and diseased tissue samples.
“APAC is projected to witness the highest growth during the forecast period.”
North America held the largest share of the global slide stainers market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, the large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.
Read More about this report: https://watchersofmarkets.com/products/slide-stainer-market-by-product-reagent-equipment-automated-manual-technology-hematoxylin-eosin-immunohistochemistry-in-situ-hybridization-microbiology-special-stains-end-user-hospital-pharmaceutical-academic-global-forecast-to-2023
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–31%, Tier 2–46% and Tier 3–23%
• By Designation – C-level–42%, Director Level–26%, Others–32%
• By Region – North America–35%, Europe–30%, Asia Pacific–21%, RoW–14%
The prominent players in the global slide stainers market are Roche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US).
Related Report:
Blood Culture Test Market by Method (Manual Automated) Product (Consumables Instrument) Application (Aerobic Anaerobic Yeast Fungi) & End User (Hospital Reference Laboratory Clinical Laboratory Academic Research Institute) - Forecast to 2019
The blood culture test market is categorized on the basis of methods, products, applications, end users, and regions. Factors such as increasing demand for rapid diagnostic techniques, high prevalence of infectious diseases, increase in healthcare expenditure and rising aging population are driving the growth of this market. Moreover, increasing blood stream infections (BSI) is another major factor propelling the growth of this market. According to the U.S. CDC (Centres for Disease Control and Prevention), catheter-related blood stream infection (CRBSI) is the most common cause for healthcare-associated blood stream infection. Around 12% to 25% of patients who acquire BSI die every year while some of them have to prolong their hospital stay leading to increase in the overall treatment cost. A treatment of CRBSI can cost up to $56,000, once the cost of pharmacy increases, the cost of catheter and additional diagnostic tests also increases which leads to the increase in the overall healthcare cost.
Read More: https://watchersofmarkets.com/products/blood-culture-test-market-by-method-manual-automated-product-consumables-instrument-application-aerobic-anaerobic-yeast-fungi-end-user-hospital-reference-laboratory-clinical-laboratory-academic-research-institute-forecast-to-2019
About Us:
We are a leading market research store (headquartered in The Hague, Netherlands) bringing to you market research insights, analysis and data from many market research publishers around the globe.
Our experienced market research consultants understand a client’s research requirements in precise manner and get as many proposals around the globe as possible on the table suiting your budget and mapping your research goals.
Our only motivation is to provide clients with precise insights into their respective niche markets and offering them the most comprehensive portfolio of business information products.
Contact:
Watchers of Markets
Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.
Website: https://watchersofmarkets.com/
Phone number: +31- 85 888 111 6
Email Id : sales@watchersofmarkets.com